RPG Life Sciences Ltd — Quarterly Results & Earnings

₹1864.60

-2.96%

Profit Growth YoY38.23%Latest quarter

Sales Growth YoY5.50%Latest quarter

Sales CAGR 5Y11.71%5 year compound

Profit CAGR 5Y28.54%5 year compound

📋

Quarterly Performance

YoY Profit Growth+38.23%

🔥 Exceptional growth

YoY Sales Growth+5.50%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

21.43%

EPS Growth 5Y

28.54%

Interest Coverage

Higher = safer debt servicing

265.64

ROE

25.53%

ROCE

32.80%

💡

Growth Analysis

RPG Life Sciences Ltd reported YoY profit growth of 38.23% and revenue growth of 5.50% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 11.71% and profits at 28.54% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on RPG Life Sciences Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.